αCP Poly(C) Binding Proteins Act as Global Regulators of Alternative Polyadenylation

Molecular and Cellular Biology

Volumn 33, Issue 13, 2013, Pages 2560-2573

  Ji, Xinjun ^a   Wan, Ji ^b,c   Vishnu, Melanie ^a   Xing, Yi ^c,d   Liebhaber, Stephen A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHACP PROTEIN; POLYADENYLIC ACID; POLYCYTIDYLIC ACID; PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; POLYADENYLATION; PRIORITY JOURNAL; RNA SEQUENCE;

3' UNTRANSLATED REGIONS; ALPHA-GLOBINS; BASE SEQUENCE; BINDING SITES; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; K562 CELLS; MOLECULAR SEQUENCE DATA; POLY A; POLYADENYLATION; RNA 3' END PROCESSING; RNA, MESSENGER; RNA-BINDING PROTEINS; TRANSCRIPTOME;

EID: 84880787940     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01380-12     Document Type: Article

References (66)

1. Keene JD. 2010. Minireview: global regulation and dynamics of ribonucleic acid. Endocrinology 151:1391-1397.
2. Moore MJ. 2005. From birth to death: the complex lives of eukaryotic mRNAs. Science 309:1514-1518.
3. Glisovic T, Bachorik JL, Yong J, Dreyfuss G. 2008. RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett. 582:1977-1986.
4. Ji X, Kong J, Liebhaber SA. 2011. An RNA-protein complex links enhanced nuclear 3' processing with cytoplasmic mRNA stabilization. EMBO J. 30:2622-2633.
5. Zhao W, Blagev D, Pollack JL, Erle DJ. 2011. Toward a systematic understanding of mRNA 3' untranslated regions. Proc. Am. Thorac. Soc. 8:163-166.
6. Colgan DF, Manley JL. 1997. Mechanism and regulation of mRNA polyadenylation. Genes Dev. 11:2755-2766.
7. Di Giammartino DC, Nishida K, Manley JL. 2011. Mechanisms and consequences of alternative polyadenylation. Mol. Cell 43:853-866.
8. Hsin JP, Manley JL. 2012. The RNA polymerase II CTD coordinates transcription and RNA processing. Genes Dev. 26:2119-2137.
9. Hsin JP, Sheth A, Manley JL. 2011. RNAP II CTD phosphorylated on threonine-4 is required for histone mRNA 3' end processing. Science 334: 683-686.
10. Richard P, Manley JL. 2009. Transcription termination by nuclear RNA polymerases. Genes Dev. 23:1247-1269.
11. Tian B, Hu J, Zhang H, Lutz CS. 2005. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res. 33:201-212.
12. Shi Y. 2012. Alternative polyadenylation: new insights from global analyses. RNA 18:2105-2117.
13. Mayr C, Bartel DP. 2009. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138:673-684.
14. Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB. 2008. Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science 320:1643-1647.
15. Ji Z, Lee JY, Pan Z, Jiang B, Tian B. 2009. Progressive lengthening of 3' untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development. Proc. Natl. Acad. Sci. U. S. A. 106:7028-7033.
16. Gilmartin GM. 1997. In vitro analysis of mammalian cell mRNA 3' processing, p 79-98. In Richter JD (ed), mRNA formation and function. Academic Press, New York, NY.
17. Moore CL, Sharp PA. 1985. Accurate cleavage and polyadenylation of exogenous RNA substrate. Cell 41:845-855.
18. Mandel CR, Bai Y, Tong L. 2008. Protein factors in pre-mRNA 3'-end processing. Cell. Mol. Life Sci. 65:1099-1122.
19. Buratowski S. 2009. Progression through the RNA polymerase II CTD cycle. Mol. Cell 36:541-546.
20. Nagaike T, Logan C, Hotta I, Rozenblatt-Rosen O, Meyerson M, Manley JL. 2011. Transcriptional activators enhance polyadenylation of mRNA precursors. Mol. Cell 41:409-418.
21. Shi Y, Di Giammartino DC, Taylor D, Sarkeshik A, Rice WJ, Yates JR, III, Frank J, Manley JL. 2009. Molecular architecture of the human pre-mRNA 3' processing complex. Mol. Cell 33:365-376.
22. Millevoi S, Vagner S. 2010. Molecular mechanisms of eukaryotic premRNA 3' end processing regulation. Nucleic Acids Res. 38:2757-2774.
23. Yao C, Biesinger J, Wan J, Weng L, Xing Y, Xie X, Shi Y. 2012. Transcriptome-wide analyses of CstF64-RNA interactions in global regulation ofmRNAalternative polyadenylation. Proc. Natl. Acad. Sci. U. S. A. 109:18773-18778.
24. Millevoi S, Decorsiere A, Loulergue C, Iacovoni J, Bernat S, Antoniou M, Vagner S. 2009. A physical and functional link between splicing factors promotes pre-mRNA 3' end processing. Nucleic Acids Res. 37:4672-4683.
25. Danckwardt S, Hentze MW, Kulozik AE. 2008. 3' end mRNA processing: molecular mechanisms and implications for health and disease. EMBO J. 27:482-498.
26. Brackenridge S, Proudfoot NJ. 2000. Recruitment of a basal polyadenylation factor by the upstream sequence element of the human lamin B2 polyadenylation signal. Mol. Cell. Biol. 20:2660-2669.
27. Ji X, Kong J, Liebhaber SA. 2003. In vivo association of the stability control protein alphaCP with actively translating mRNAs. Mol. Cell. Biol. 23:899-907.
28. Kiledjian M, Wang X, Liebhaber SA. 1995. Identification of two KH domain proteins in the alpha-globin mRNP stability complex. EMBO J. 14:4357-4364.
29. Kong J, Ji X, Liebhaber SA. 2003. The KH-domain protein alpha CP has a direct role in mRNA stabilization independent of its cognate binding site. Mol. Cell. Biol. 23:1125-1134.
30. Kong J, Liebhaber SA. 2007. A cell type-restricted mRNA surveillance pathway triggered by ribosome extension into the 3' untranslated region. Nat. Struct. Mol. Biol. 14:670-676.
31. Weiss IM, Liebhaber SA. 1994. Erythroid cell-specific determinants of alpha-globin mRNA stability. Mol. Cell. Biol. 14:8123-8132.
32. Weiss IM, Liebhaber SA. 1995. Erythroid cell-specific mRNA stability elements in the alpha 2-globin 3' nontranslated region. Mol. Cell. Biol. 15:2457-2465.
33. Makeyev AV, Liebhaber SA. 2002. The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. RNA 8:265-278.
34. Chkheidze AN, Lyakhov DL, Makeyev AV, Morales J, Kong J, Liebhaber SA. 1999. Assembly of the alpha-globin mRNA stability complex reflects binary interaction between the pyrimidine-rich 3' untranslated region determinant and poly(C) binding protein alphaCP. Mol. Cell. Biol. 19:4572-4581.
35. Thisted T, Lyakhov DL, Liebhaber SA. 2001. Optimized RNA targets of two closely related triple KH domain proteins, heterogeneous nuclear ribonucleoprotein K and alphaCP-2KL, suggest distinct modes of RNA recognition. J. Biol. Chem. 276:17484-17496.
36. Chaudhury A, Chander P, Howe PH. 2010. Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: focus on hnRNP E1's multifunctional regulatory roles. RNA 16:1449-1462.
37. Holcik M, Liebhaber SA. 1997. Four highly stable eukaryotic mRNAs assemble 3' untranslated region RNA-protein complexes sharing cis and trans components. Proc. Natl. Acad. Sci. U. S. A. 94:2410-2414.
38. Waggoner SA, Liebhaber SA. 2003. Identification of mRNAs associated with alphaCP2-containing RNP complexes. Mol. Cell. Biol. 23:7055-7067.
39. Waggoner SA, Liebhaber SA. 2003. Regulation of alpha-globin mRNA stability. Exp. Biol. Med. (Maywood) 228:387-395.
40. Ji X, Kong J, Carstens RP, Liebhaber SA. 2007. The 3' untranslated region complex involved in stabilization of human alpha-globin mRNA assembles in the nucleus and serves an independent role as a splice enhancer. Mol. Cell. Biol. 27:3290-3302.
41. Ozsolak F, Kapranov P, Foissac S, Kim SW, Fishilevich E, Monaghan AP, John B, Milos PM. 2010. Comprehensive polyadenylation site maps in yeast and human reveal pervasive alternative polyadenylation. Cell 143: 1018-1029.
42. Ozsolak F, Platt AR, Jones DR, Reifenberger JG, Sass LE, McInerney P, Thompson JF, Bowers J, Jarosz M, Milos PM. 2009. Direct RNA sequencing. Nature 461:814-818.
43. Fu Y, Sun Y, Li Y, Li J, Rao X, Chen C, Xu A. 2011. Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing. Genome Res. 21:741-747.
44. Wang L, Feng Z, Wang X, Wang X, Zhang X. 2010. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 26:136-138.
45. Bailey TL, Boden M, Buske FA, Frith M, Grant CE, Clementi L, Ren J, Li WW, Noble WS. 2009. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37:W202-W208.
46. Huang DW, Sherman BT, Lempicki RA. 2009. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37:1-13.
47. Lee JY, Yeh I, Park JY, Tian B. 2007. PolyA_DB 2: mRNA polyadenylation sites in vertebrate genes. Nucleic Acids Res. 35:D165-D168.
48. Ghosh D, Srivastava GP, Xu D, Schulz LC, Roberts RM. 2008. A link between SIN1 (MAPKAP1) and poly(rC) binding protein 2 (PCBP2) in counteracting environmental stress. Proc. Natl. Acad. Sci. U. S. A. 105: 11673-11678.
49. Sagawa F, Ibrahim H, Morrison AL, Wilusz CJ, Wilusz J. 2011. Nucleophosmin deposition during mRNA 3' end processing influences poly(A) tail length. EMBO J. 30:3994-4005.
50. Xiang K, Manley JL, Tong L. 2012. An unexpected binding mode for a Pol II CTD peptide phosphorylated at Ser7 in the active site of the CTD phosphatase Ssu72. Genes Dev. 26:2265-2270.
51. Xiang K, Nagaike T, Xiang S, Kilic T, Beh MM, Manley JL, Tong L. 2010. Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex. Nature 467:729-733.
52. Perrotti D, Calabretta B. 2004. Translational regulation by the p210 BCR/ABL oncoprotein. Oncogene 23:3222-3229.
53. Jenal M, Elkon R, Loayza-Puch F, van Haaften G, Kuhn U, Menzies FM, Oude Vrielink JA, Bos AJ, Drost J, Rooijers K, Rubinsztein DC, Agami R. 2012. The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. Cell 149:538-553.
54. Licatalosi DD, Mele A, Fak JJ, Ule J, Kayikci M, Chi SW, Clark TA, Schweitzer AC, Blume JE, Wang X, Darnell JC, Darnell RB. 2008. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456:464-469.
55. Hall-Pogar T, Liang S, Hague LK, Lutz CS. 2007. Specific trans-acting proteins interact with auxiliary RNA polyadenylation elements in the COX-2 3'-UTR. RNA 13:1103-1115.
56. Moreira A, Takagaki Y, Brackenridge S, Wollerton M, Manley JL, Proudfoot NJ. 1998. The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms. Genes Dev. 12:2522-2534.
57. Katz Y, Wang ET, Airoldi EM, Burge CB. 2010. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat. Methods 7:1009-1015.
58. Dittmar KA, Jiang P, Park JW, Amirikian K, Wan J, Shen S, Xing Y, Carstens RP. 2012. Genome-wide determination of a broad ESRPregulated posttranscriptional network by high-throughput sequencing. Mol. Cell. Biol. 32:1468-1482.
59. Naarmann IS, Harnisch C, Flach N, Kremmer E, Kuhn H, Ostareck DH, Ostareck-Lederer A. 2008. mRNA silencing in human erythroid cell maturation: heterogeneous nuclear ribonucleoprotein K controls the expression of its regulator c-Src. J. Biol. Chem. 283:18461-18472.
60. Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K, Iervolino A, Condorelli F, Gambacorti-Passerini C, Caligiuri MA, Calabretta B. 2002. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2. Nat. Genet. 30:48-58.
61. Buratti E, Baralle FE. 2011. TDP-43: new aspects of autoregulation mechanisms in RNA binding proteins and their connection with human disease. FEBS J. 278:3530-3538.
62. Zhu J, Chen X. 2000. MCG10, a novel p53 target gene that encodes a KH domain RNA-binding protein, is capable of inducing apoptosis and cell cycle arrest in G(2)-M. Mol. Cell. Biol. 20:5602-5618.
63. Chaudhury A, Hussey GS, Ray PS, Jin G, Fox PL, Howe PH. 2010. TGF-beta-mediated phosphorylation of hnRNP E1 inducesEMTvia transcript-selective translational induction of Dab2 and ILEI. Nat. Cell Biol. 12:286-293.
64. Perrotti D, Calabretta B. 2002. Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins. Oncogene 21:8577-8583.
65. Molinaro RJ, Jha BK, Malathi K, Varambally S, Chinnaiyan AM, Silverman RH. 2006. Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cells. Nucleic Acids Res. 34:6684-6695.
66. Chang JS, Santhanam R, Trotta R, Neviani P, Eiring AM, Briercheck E, Ronchetti M, Roy DC, Calabretta B, Caligiuri MA, Perrotti D. 2007. High levels of the BCR/ABL oncoprotein are required for the MAPKhnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation. Blood 110:994-1003.